Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | H4K3S | — |
Accidentally administered with Boostrix instead of Fluad; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 89-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number H4K3S, expiry date 30-OCT-2027) for prophylaxis. Co-suspect products included Influenza vaccine inact sAg 3v (Fluad) for prophylaxis. Previously administered products included Boostrix (received 1st dose of vaccine on 10th June 2022). Concomitant products included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20). On 02-SEP-2025, the patient received Boostrix. The patient did not receive Fluad. On 02-SEP-2025, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: Accidentally administered with Boostrix instead of Fluad). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-SEP-2025 On 2nd September 2025, Patient had come in to receive pneumonia and flu vaccines. However, they appeared to have been mistakenly given Boostrix instead of Fluad. Patient also received Prevnar 20 on the same day. Patient had previously received their first dose of Boostrix on 10th June 2022.; Sender's Comments: US-GSK-US2025124892:deleted/duplicate case
PREVNAR 20